R. Arnold
711 works · 20,688 citations · h-index 66
Top works
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- Glucagon‐like peptide‐1 cells in the gastrointestinal tract and pancreas of rat, pig and man
- Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
- Glucagon-Like Peptide-1 and Glucose-Dependent Insulin-Releasing Polypeptide Plasma Levels in Response to Nutrients
- Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.
- Gastric emptying and release of incretin hormones after glucose ingestion in humans.
- Gastrin and G‐Cells in the Antral Mucosa of Patients with Pernicious Anaemia, Acromegaly and Hyperparathyroidism and in a Zollinger‐Ellison Tumour of the Pancreas
- ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
- Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome)
- Biochemical and morphological investigations of 30 human insulinomas
- Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
- Influence of Feeding and Sham Feeding upon Serum Gastrin and Gastric Acid Secretion in Control Subjects and Duodenal Ulcer Patients
- Octreotide Versus Octreotide Plus Interferon-Alpha in Endocrine Gastroenteropancreatic Tumors: A Randomized Trial
- Glucose-Dependent Insulinotropic Polypeptide Is a Growth Factor for β (INS-1) Cells by Pleiotropic Signaling
- Gastric inhibitory polypeptide (GIP), gastrin and insulin: Response to test meal in coeliac disease and after duodeno-pancreatectomy
- Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia
- Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
- Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies
- Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose